» Articles » PMID: 35836654

Advances and Perspective on the Translational Medicine of Biodegradable Metals

Overview
Journal Biomater Transl
Date 2022 Jul 15
PMID 35836654
Authors
Affiliations
Soon will be listed here.
Abstract

Biodegradable metals, designed to be safely degraded and absorbed by the body after fulfil the intended functions, are of particular interest in the 21 century. The marriage of advanced biodegradable metals with clinical needs have yield unprecedented possibility. Magnesium, iron, and zinc-based materials constitute the main components of temporary, implantable metallic medical devices. A burgeoning number of studies on biodegradable metals have driven the clinical translation of biodegradable metallic devices in the fields of cardiology and orthopaedics over the last decade. Their ability to degrade as well as their beneficial biological functions elicited during degradation endow this type of material with the potential to shift the paradigm in the treatment of musculoskeletal and cardiovascular diseases. This review provides an insight into the degradation mechanism of these metallic devices in specific application sites and introduces state-of-the-art translational research in the field of biodegradable metals, as well as highlighting some challenges for materials design strategies in the context of mechanical and biological compatibility.

Citing Articles

Next-generation aluminum adjuvants: Immunomodulatory layered double hydroxide NanoAlum reengineered from first-line drugs.

Su Z, Boucetta H, Shao J, Huang J, Wang R, Shen A Acta Pharm Sin B. 2024; 14(11):4665-4682.

PMID: 39664431 PMC: 11628803. DOI: 10.1016/j.apsb.2024.09.012.


Magnesium-based biodegradable metal materials: past, present and future.

Guo X, Wang Q Biomater Transl. 2022; 2(3):175-176.

PMID: 35836653 PMC: 9255804. DOI: 10.12336/biomatertransl.2021.03.001.


Recent Advances of Microneedles and Their Application in Disease Treatment.

Zhang W, Zhang W, Li C, Zhang J, Qin L, Lai Y Int J Mol Sci. 2022; 23(5).

PMID: 35269545 PMC: 8909978. DOI: 10.3390/ijms23052401.

References
1.
Wentzel J, Whelan D, van der Giessen W, van Beusekom H, Andhyiswara I, Serruys P . Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution. J Biomech. 2000; 33(10):1287-95. DOI: 10.1016/s0021-9290(00)00066-x. View

2.
Bennett J, de Hemptinne Q, McCutcheon K . Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy. Expert Rev Med Devices. 2019; 16(9):757-769. DOI: 10.1080/17434440.2019.1649133. View

3.
Shen D, Qi H, Lin W, Zhang W, Bian D, Shi X . PDLLA-Zn-nitrided Fe bioresorbable scaffold with 53-μm-thick metallic struts and tunable multistage biodegradation function. Sci Adv. 2021; 7(23). PMC: 8177708. DOI: 10.1126/sciadv.abf0614. View

4.
He J, Fang J, Wei P, Li Y, Guo H, Mei Q . Cancellous bone-like porous Fe@Zn scaffolds with core-shell-structured skeletons for biodegradable bone implants. Acta Biomater. 2020; 121:665-681. DOI: 10.1016/j.actbio.2020.11.032. View

5.
Haude M, Ince H, Kische S, Abizaid A, Tolg R, Lemos P . Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. Catheter Cardiovasc Interv. 2018; 92(7):E502-E511. PMC: 6586164. DOI: 10.1002/ccd.27680. View